Rosiglitazone Extended Release 2mg

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Alzheimer's Disease

Phase 3

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease

CompletedNCT00348140

GlaxoSmithKlineAlzheimer's Disease

Start: 2006-07-12End: 2009-03-20Updated: 2017-09-05

Unknown Phase

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

CompletedNCT00348309

GlaxoSmithKlineAlzheimer's Disease

Start: 2006-07-06End: 2009-01-28Updated: 2017-11-28